Inflammatory Bowel Diseases, ISSN 1078-0998, 01/2015, Volume 21, Issue 3, pp. 703 - 715
Chronic proctitis refers to persistent or relapsing inflammation of the rectum, which results from a wide range of etiologies with various pathogenic...
diagnosis | radiation proctitis | ulcerative proctitis | proctopathy | management | diversion proctitis | 5-ASA COLONIC FOAM | DOSE COMBINATION RADIOTHERAPY | YAG LASER TREATMENT | INFLAMMATORY-BOWEL-DISEASE | HYPERBARIC-OXYGEN THERAPY | CHAIN FATTY-ACIDS | PROSTATE-CANCER | DOUBLE-BLIND | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | ARGON PLASMA COAGULATION | Proctitis - etiology | Animals | Proctitis - prevention & control | Radiation Injuries - prevention & control | Proctitis - diagnosis | Humans | Radiation Injuries - diagnosis | Disease Management | Radiotherapy - adverse effects | Chronic Disease | Radiation Injuries - etiology
diagnosis | radiation proctitis | ulcerative proctitis | proctopathy | management | diversion proctitis | 5-ASA COLONIC FOAM | DOSE COMBINATION RADIOTHERAPY | YAG LASER TREATMENT | INFLAMMATORY-BOWEL-DISEASE | HYPERBARIC-OXYGEN THERAPY | CHAIN FATTY-ACIDS | PROSTATE-CANCER | DOUBLE-BLIND | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | ARGON PLASMA COAGULATION | Proctitis - etiology | Animals | Proctitis - prevention & control | Radiation Injuries - prevention & control | Proctitis - diagnosis | Humans | Radiation Injuries - diagnosis | Disease Management | Radiotherapy - adverse effects | Chronic Disease | Radiation Injuries - etiology
Journal Article
Inflammatory Bowel Diseases, ISSN 1078-0998, 11/2014, Volume 20, Issue 11, pp. 2157 - 2178
Background: Patients with ulcerative colitis limited to the proctum are considered to have ulcerative proctitis (UP). In patients with more extensive...
Therapy | Ulcerative proctitis | Ulcerative colitis | GLUCOCORTICOSTEROID THERAPY | CLINICAL-TRIAL | therapy | TOPICAL TREATMENT | ulcerative proctitis | 5-AMINOSALICYLIC ACID | FOAM ENEMA | INFLAMMATORY-BOWEL-DISEASE | BUDESONIDE ENEMA | DOUBLE-BLIND | ulcerative colitis | MESALAZINE SUPPOSITORIES | IDIOPATHIC PROCTITIS | GASTROENTEROLOGY & HEPATOLOGY | Anti-Inflammatory Agents - therapeutic use | Disease Management | Colitis, Ulcerative - drug therapy | Humans | Proctitis - drug therapy | Crohn Disease - surgery
Therapy | Ulcerative proctitis | Ulcerative colitis | GLUCOCORTICOSTEROID THERAPY | CLINICAL-TRIAL | therapy | TOPICAL TREATMENT | ulcerative proctitis | 5-AMINOSALICYLIC ACID | FOAM ENEMA | INFLAMMATORY-BOWEL-DISEASE | BUDESONIDE ENEMA | DOUBLE-BLIND | ulcerative colitis | MESALAZINE SUPPOSITORIES | IDIOPATHIC PROCTITIS | GASTROENTEROLOGY & HEPATOLOGY | Anti-Inflammatory Agents - therapeutic use | Disease Management | Colitis, Ulcerative - drug therapy | Humans | Proctitis - drug therapy | Crohn Disease - surgery
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 02/2019, Volume 31, Issue 2, pp. 183 - 186
BACKGROUNDMesalazine-refractory ulcerative proctitis is common, with a significant proportion of the patients requiring escalation to immunomodulators or...
acetarsol | ulcerative colitis | ulcerative proctitis | refractory proctitis | EFFICACY | COLITIS | SUPPOSITORIES | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | Mesalamine | Treatment outcome | Dosage and administration | Proctitis | Drug therapy | Analysis
acetarsol | ulcerative colitis | ulcerative proctitis | refractory proctitis | EFFICACY | COLITIS | SUPPOSITORIES | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | Mesalamine | Treatment outcome | Dosage and administration | Proctitis | Drug therapy | Analysis
Journal Article
Best Practice & Research Clinical Gastroenterology, ISSN 1521-6918, 02/2018, Volume 32-33, pp. 49 - 57
Ulcerative proctitis is defined as a mucosal inflammation limited to the rectum. Ulcerative proctitis is responsible for distressing symptoms and alteration of...
Refractory ulcerative proctitis | Inflammatory bowel disease | Anti-TNF | Treatment | Azathioprine | Surgery | Mesalamine | Proctitis | Epidermal growth factor | Tacrolimus | Monoclonal antibodies | Bismuth | Drug therapy | Ulcerative colitis | Colitis, Ulcerative | Life Sciences | Human health and pathology | Humans | Quality of Life | Treatment Outcome | Cancer
Refractory ulcerative proctitis | Inflammatory bowel disease | Anti-TNF | Treatment | Azathioprine | Surgery | Mesalamine | Proctitis | Epidermal growth factor | Tacrolimus | Monoclonal antibodies | Bismuth | Drug therapy | Ulcerative colitis | Colitis, Ulcerative | Life Sciences | Human health and pathology | Humans | Quality of Life | Treatment Outcome | Cancer
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2009, Volume 104, Issue 10, pp. 2476 - 2482
OBJECTIVES: Available data regarding whether appendicectomy performed after the onset of ulcerative colitis can modulate its clinical course are currently...
INFLAMMATORY-BOWEL-DISEASE | CROHNS-DISEASE | COLITIS | SKIP LESION | ENVIRONMENTAL RISK-FACTORS | GASTROENTEROLOGY & HEPATOLOGY | PROTECTS | Prospective Studies | Humans | Middle Aged | Male | Survival Rate | Treatment Outcome | Appendectomy - methods | Proctitis - surgery | Adolescent | Adult | Colitis, Ulcerative - surgery | Female | Aged
INFLAMMATORY-BOWEL-DISEASE | CROHNS-DISEASE | COLITIS | SKIP LESION | ENVIRONMENTAL RISK-FACTORS | GASTROENTEROLOGY & HEPATOLOGY | PROTECTS | Prospective Studies | Humans | Middle Aged | Male | Survival Rate | Treatment Outcome | Appendectomy - methods | Proctitis - surgery | Adolescent | Adult | Colitis, Ulcerative - surgery | Female | Aged
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 06/2010, Volume 31, Issue 11, pp. 1178 - 1185
Aliment Pharmacol Ther 31, 1178–1185 Summary Background Efficacy of infliximab in treating ulcerative proctitis remains unknown. Aim To evaluate the...
CONTROLLED-TRIAL | INFLAMMATORY-BOWEL-DISEASE | THERAPY | MEDICAL-MANAGEMENT | CROHNS-DISEASE | DOUBLE-BLIND | AZATHIOPRINE | PHARMACOLOGY & PHARMACY | CLINICAL-COURSE | TACROLIMUS | GASTROENTEROLOGY & HEPATOLOGY | INDETERMINATE COLITIS | Follow-Up Studies | Infliximab | Humans | Middle Aged | Gastrointestinal Agents - therapeutic use | Adult | Antibodies, Monoclonal - therapeutic use | Female | Male | Treatment Outcome | Aged | Colitis, Ulcerative - drug therapy | Proctitis | Ulcerative colitis | Life Sciences
CONTROLLED-TRIAL | INFLAMMATORY-BOWEL-DISEASE | THERAPY | MEDICAL-MANAGEMENT | CROHNS-DISEASE | DOUBLE-BLIND | AZATHIOPRINE | PHARMACOLOGY & PHARMACY | CLINICAL-COURSE | TACROLIMUS | GASTROENTEROLOGY & HEPATOLOGY | INDETERMINATE COLITIS | Follow-Up Studies | Infliximab | Humans | Middle Aged | Gastrointestinal Agents - therapeutic use | Adult | Antibodies, Monoclonal - therapeutic use | Female | Male | Treatment Outcome | Aged | Colitis, Ulcerative - drug therapy | Proctitis | Ulcerative colitis | Life Sciences
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 06/2018, Volume 33, Issue 6, pp. 1200 - 1206
Background and Aim In some patients with ulcerative proctitis (UP), skip inflammation is noted in the right side of the colon, but little is known about its...
skip inflammation | progression | ulcerative proctitis | 5‐aminosalicylate | monotherapy | exacerbation | 5-aminosalicylate | MUCOSAL INFLAMMATION | MESALAMINE | EXTENSION | MESALAZINE | MAINTENANCE | THERAPY | COLITIS | APPENDICEAL ORIFICE INFLAMMATION | SUPPOSITORIES | GASTROENTEROLOGY & HEPATOLOGY | REMISSION | Medicine, Experimental | Medical research | Development and progression | Care and treatment | Inflammation | Proctitis | Remission | Colon | Patients
skip inflammation | progression | ulcerative proctitis | 5‐aminosalicylate | monotherapy | exacerbation | 5-aminosalicylate | MUCOSAL INFLAMMATION | MESALAMINE | EXTENSION | MESALAZINE | MAINTENANCE | THERAPY | COLITIS | APPENDICEAL ORIFICE INFLAMMATION | SUPPOSITORIES | GASTROENTEROLOGY & HEPATOLOGY | REMISSION | Medicine, Experimental | Medical research | Development and progression | Care and treatment | Inflammation | Proctitis | Remission | Colon | Patients
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 4, pp. 740 - 750.e2
Background & Aims Budesonide is a high-potency, second-generation corticosteroid designed to minimize systemic adverse consequences of conventional...
Gastroenterology and Hepatology | Budesonide | Inflammatory Bowel Disease | Ulcerative Proctosigmoiditis | Ulcerative Colitis | Colitis Budesonide | Ulcerative | ORAL BUDESONIDE | ENEMA | THERAPEUTIC TRIAL | RANDOMIZED MULTICENTER | RELEASE | MESALAZINE | COLONIC SPREAD | INFLAMMATORY-BOWEL-DISEASE | COLITIS | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | Glucocorticoids - administration & dosage | Double-Blind Method | Colon, Sigmoid | Humans | Middle Aged | Proctitis - drug therapy | Proctocolitis - drug therapy | Administration, Rectal | Male | Treatment Outcome | Ulcer - drug therapy | Adult | Female | Remission Induction - methods | Budesonide - administration & dosage | Administration, Topical | Care and treatment | Proctitis | Corticosteroids | Steroids
Gastroenterology and Hepatology | Budesonide | Inflammatory Bowel Disease | Ulcerative Proctosigmoiditis | Ulcerative Colitis | Colitis Budesonide | Ulcerative | ORAL BUDESONIDE | ENEMA | THERAPEUTIC TRIAL | RANDOMIZED MULTICENTER | RELEASE | MESALAZINE | COLONIC SPREAD | INFLAMMATORY-BOWEL-DISEASE | COLITIS | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | Glucocorticoids - administration & dosage | Double-Blind Method | Colon, Sigmoid | Humans | Middle Aged | Proctitis - drug therapy | Proctocolitis - drug therapy | Administration, Rectal | Male | Treatment Outcome | Ulcer - drug therapy | Adult | Female | Remission Induction - methods | Budesonide - administration & dosage | Administration, Topical | Care and treatment | Proctitis | Corticosteroids | Steroids
Journal Article
International Journal of Colorectal Disease, ISSN 0179-1958, 2/2019, Volume 34, Issue 2, pp. 359 - 362
In the last years, there was a rising in the incidence of sexually transmitted infections, including proctitis. Infectious proctitis (IP), mainly caused by...
Medicine & Public Health | Surgery | Hepatology | Gastroenterology | Internal Medicine | Rectal inflammation | Proctology | Sexually transmitted infections | Clinical history | SURGERY | MANAGEMENT | LYMPHOGRANULOMA-VENEREUM | GASTROENTEROLOGY & HEPATOLOGY | Diagnosis, Differential | Colitis, Ulcerative - virology | Intraabdominal Infections - microbiology | Humans | Middle Aged | Male | Intraabdominal Infections - diagnosis | Intraabdominal Infections - parasitology | Colitis, Ulcerative - parasitology | Young Adult | Colitis, Ulcerative - diagnosis | Colitis, Ulcerative - microbiology | Proctitis - diagnosis | Intraabdominal Infections - virology | Adult | Inflammatory bowel diseases | Anorectal | Serology | Gonorrhea | Patients | Risk factors | Inflammatory bowel disease | Proctitis | Pain | Antibiotics | Intestine | Etiology | Human immunodeficiency virus--HIV | Rectum | Differential diagnosis | Sexual partners | Ulcerative colitis
Medicine & Public Health | Surgery | Hepatology | Gastroenterology | Internal Medicine | Rectal inflammation | Proctology | Sexually transmitted infections | Clinical history | SURGERY | MANAGEMENT | LYMPHOGRANULOMA-VENEREUM | GASTROENTEROLOGY & HEPATOLOGY | Diagnosis, Differential | Colitis, Ulcerative - virology | Intraabdominal Infections - microbiology | Humans | Middle Aged | Male | Intraabdominal Infections - diagnosis | Intraabdominal Infections - parasitology | Colitis, Ulcerative - parasitology | Young Adult | Colitis, Ulcerative - diagnosis | Colitis, Ulcerative - microbiology | Proctitis - diagnosis | Intraabdominal Infections - virology | Adult | Inflammatory bowel diseases | Anorectal | Serology | Gonorrhea | Patients | Risk factors | Inflammatory bowel disease | Proctitis | Pain | Antibiotics | Intestine | Etiology | Human immunodeficiency virus--HIV | Rectum | Differential diagnosis | Sexual partners | Ulcerative colitis
Journal Article
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, ISSN 0269-2813, 07/2017, Volume 46, Issue 2, pp. 205 - 205
Journal Article
Scandinavian Journal of Gastroenterology, ISSN 0036-5521, 02/2014, Volume 49, Issue 2, pp. 177 - 183
Abstract Objective. Ulcerative colitis usually involves the rectum, may extend in a proximal and continuous fashion to involve varying portions of the bowel....
progression | ulcerative colitis | disease extension | proctitis | Progression | Proctitis | Disease extension | Ulcerative colitis | IBSEN | FOLLOW-UP | NATURAL-HISTORY | CLINICAL-COURSE | INFLAMMATORY-BOWEL-DISEASE | THERAPY | COLITIS | COHORT | GASTROENTEROLOGY & HEPATOLOGY | Severity of Illness Index | Recurrence | Proctocolitis - pathology | Sigmoidoscopy | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Male | Colitis, Ulcerative - pathology | Hospitalization | Disease Progression | Young Adult | Adult | Female | Retrospective Studies | Colon
progression | ulcerative colitis | disease extension | proctitis | Progression | Proctitis | Disease extension | Ulcerative colitis | IBSEN | FOLLOW-UP | NATURAL-HISTORY | CLINICAL-COURSE | INFLAMMATORY-BOWEL-DISEASE | THERAPY | COLITIS | COHORT | GASTROENTEROLOGY & HEPATOLOGY | Severity of Illness Index | Recurrence | Proctocolitis - pathology | Sigmoidoscopy | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Male | Colitis, Ulcerative - pathology | Hospitalization | Disease Progression | Young Adult | Adult | Female | Retrospective Studies | Colon
Journal Article
Journal of Clinical Gastroenterology, ISSN 0192-0790, 11/2015, Volume 49, Issue 10, pp. 853 - 857
BACKGROUND AND AIMS:Sacral nerve stimulation (SNS) is recognized for its efficiency and safety for anal incontinence, preventing high morbidity. Evidence from...
Ulcerative proctitis | Neuromodulation | Enteric nervous system | neuromodulation | FECAL INCONTINENCE | COLITIS | DISEASE | BARRIER | ulcerative proctitis | enteric nervous system | GASTROENTEROLOGY & HEPATOLOGY | Proctocolitis - physiopathology | Tight Junction Proteins - genetics | Cytokines - metabolism | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Treatment Outcome | Combined Modality Therapy | Permeability | RNA, Messenger - metabolism | Electric Stimulation Therapy - methods | Time Factors | Colonoscopy | Proctocolitis - complications | Female | Sacrum - innervation | Fecal Incontinence - etiology | Fecal Incontinence - therapy | Proctocolitis - therapy | Tight Junction Proteins - metabolism
Ulcerative proctitis | Neuromodulation | Enteric nervous system | neuromodulation | FECAL INCONTINENCE | COLITIS | DISEASE | BARRIER | ulcerative proctitis | enteric nervous system | GASTROENTEROLOGY & HEPATOLOGY | Proctocolitis - physiopathology | Tight Junction Proteins - genetics | Cytokines - metabolism | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Treatment Outcome | Combined Modality Therapy | Permeability | RNA, Messenger - metabolism | Electric Stimulation Therapy - methods | Time Factors | Colonoscopy | Proctocolitis - complications | Female | Sacrum - innervation | Fecal Incontinence - etiology | Fecal Incontinence - therapy | Proctocolitis - therapy | Tight Junction Proteins - metabolism
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2017, Volume 15, Issue 8, pp. 1248 - 1255
Background & Aims Resistant ulcerative proctitis can be extremely difficult to manage. Topically administered tacrolimus, however, may be effective in...
Gastroenterology and Hepatology | Blinded Randomized Clinical Trial | Proctitis | Tacrolimus | Ulcerative Colitis | DISTAL COLITIS | MANAGEMENT | CROHNS-DISEASE | MAINTENANCE THERAPY | ORAL TACROLIMUS | INFLAMMATORY-BOWEL-DISEASE | CALCINEURIN | HOST-DISEASE | TOPICAL TACROLIMUS | SKIN | GASTROENTEROLOGY & HEPATOLOGY | Medical colleges | Medical research | Care and treatment | Medicine, Experimental | Research institutes | Ulcerative colitis | Analysis
Gastroenterology and Hepatology | Blinded Randomized Clinical Trial | Proctitis | Tacrolimus | Ulcerative Colitis | DISTAL COLITIS | MANAGEMENT | CROHNS-DISEASE | MAINTENANCE THERAPY | ORAL TACROLIMUS | INFLAMMATORY-BOWEL-DISEASE | CALCINEURIN | HOST-DISEASE | TOPICAL TACROLIMUS | SKIN | GASTROENTEROLOGY & HEPATOLOGY | Medical colleges | Medical research | Care and treatment | Medicine, Experimental | Research institutes | Ulcerative colitis | Analysis
Journal Article
Digestive and Liver Disease, ISSN 1590-8658, 2016, Volume 49, Issue 3, pp. 280 - 285
Abstract Background Efficacy of azathioprine (AZA) in refractory ulcerative proctitis (UP) is unknown. Methods All patients treated with AZA for refractory UP...
Gastroenterology and Hepatology | Azathioprine | Proctitis | Ulcerative colitis | CONTROLLED-TRIAL | PLACEBO | MANAGEMENT | CONSENSUS | INFLAMMATORY-BOWEL-DISEASE | THERAPY | TACROLIMUS | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | INDETERMINATE COLITIS | REMISSION | Azathioprine - therapeutic use | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Proctitis - drug therapy | Male | Treatment Outcome | Colectomy | Infliximab - therapeutic use | Young Adult | Adult | Female | Immunosuppressive Agents - adverse effects | Aged | Retrospective Studies | Colitis, Ulcerative - drug therapy | Drug Therapy, Combination | France | Azathioprine - adverse effects | Child | Medicine, Experimental | Medical research | Life Sciences | Medication | Human health and pathology | Hépatology and Gastroenterology | Pharmaceutical sciences
Gastroenterology and Hepatology | Azathioprine | Proctitis | Ulcerative colitis | CONTROLLED-TRIAL | PLACEBO | MANAGEMENT | CONSENSUS | INFLAMMATORY-BOWEL-DISEASE | THERAPY | TACROLIMUS | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | INDETERMINATE COLITIS | REMISSION | Azathioprine - therapeutic use | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Proctitis - drug therapy | Male | Treatment Outcome | Colectomy | Infliximab - therapeutic use | Young Adult | Adult | Female | Immunosuppressive Agents - adverse effects | Aged | Retrospective Studies | Colitis, Ulcerative - drug therapy | Drug Therapy, Combination | France | Azathioprine - adverse effects | Child | Medicine, Experimental | Medical research | Life Sciences | Medication | Human health and pathology | Hépatology and Gastroenterology | Pharmaceutical sciences
Journal Article
15.
Full Text
Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 01/2019, Volume 17, Issue 1, pp. 98 - 106.e4
Although proctitis is the most limited form of ulcerative colitis, it causes unpleasant symptoms. Topical mesalamine, the standard treatment, is not always...
RCT | Inflammatory Bowel Disease | Mesalazine | Ulcerative Colitis | CLINICAL-TRIAL | INDUCTION | 5-AMINOSALICYLIC ACID | MILD | MESALAZINE ENEMAS | COLITIS | FOAM | THERAPIES | MMX MESALAMINE | GASTROENTEROLOGY & HEPATOLOGY | REMISSION | Budesonide | Proctitis | Ulcerative colitis | Steroids
RCT | Inflammatory Bowel Disease | Mesalazine | Ulcerative Colitis | CLINICAL-TRIAL | INDUCTION | 5-AMINOSALICYLIC ACID | MILD | MESALAZINE ENEMAS | COLITIS | FOAM | THERAPIES | MMX MESALAMINE | GASTROENTEROLOGY & HEPATOLOGY | REMISSION | Budesonide | Proctitis | Ulcerative colitis | Steroids
Journal Article